Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Induction chemotherapy plus chemoradiotherapy in esophageal cancer: long-term results and exploratory analyses of a randomized controlled trial
Liu, Shiliang; Chen, Baoqing; Zhu, Yujia; Wang, Sifen; Cheng, Xingyuan; Wang, Ruixi; Hu, Yonghong; Liu, Hui; Li, Qiaoqiao; Zhang, Li; Zhao, Lei; Liu, Mengzhong; Xi, Mian Share Save Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for oesophageal squamous cell carcinoma: insights from the EC-CRT-001 phase II trialWang, Ruixi; Ling, Yihong; Chen, Baoqing; Zhu, Yujia; Hu, Yonghong; Liu, Mengzhong; Yang, Yadi; Zhang, Li; Lv, Yingxin; Liu, Shiliang; Li, Qiaoqiao; Xi, Mian Share Save Prognostic significance of PET/CT and its association with immuno-genomic profiling in oesophageal squamous cell carcinoma treated with immunotherapy plus chemoradiotherapy: results from a phase II studyWang, Ruixi; Liu, Shiliang; Chen, Baoqing; Li, Qiaoqiao; Cheng, Xingyuan; Zhu, Yujia; Zhang, Li; Hu, Yonghong; Liu, Mengzhong; Hu, Yingying; Xi, Mian Share Save Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimabChen, Baoqing; Liu, Shiliang; Zhu, Yujia; Wang, Ruixi; Cheng, Xingyuan; Chen, Biqi; Dragomir, Mihnea P.; Zhang, Yaru; Hu, Yonghong; Liu, Mengzhong; Li, Qiaoqiao; Yang, Hong; Xi, Mian Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}